Defence Therapeutics Inc. (DTCFF)
USD 0.62
(3.69%)
USD 0.62
(3.69%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 1.74 Million CAD | 0.02% |
| 2023 | 1.74 Million CAD | 0.0% |
| 2022 | - CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 1.74 Million CAD | 9.05% |
| 2024 Q2 | 1.51 Million CAD | -7.54% |
| 2024 Q1 | 1.63 Million CAD | -6.19% |
| 2024 Q3 | 1.6 Million CAD | 5.75% |
| 2023 Q1 | - CAD | 0.0% |
| 2023 FY | 1.74 Million CAD | 0.0% |
| 2023 Q4 | 1.74 Million CAD | 6.3% |
| 2023 Q3 | 1.64 Million CAD | -4.63% |
| 2023 Q2 | 1.72 Million CAD | 0.0% |
| 2022 Q4 | - CAD | 0.0% |
| 2022 FY | - CAD | 0.0% |
| 2022 Q3 | - CAD | 0.0% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bioxytran, Inc. | 1.92 Million USD | 9.275% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 95.761% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -334.603% |
| SQZ Biotechnologies Company | 27.47 Million USD | 93.643% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | 24.915% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 95.973% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 94.133% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -84.172% |
| Marizyme, Inc. | 18.71 Million USD | 90.669% |
| Genus plc | 233.1 Million USD | 99.251% |
| Pharming Group N.V. | 171.54 Million USD | 98.982% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -96.658% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -29.984% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -132.86% |
| ContraFect Corporation | 2.88 Million USD | 39.38% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -20.751% |
| IMV Inc. | 28.88 Million USD | 93.954% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | 69.135% |
| ONE Bio Corp. | 19.71 Million USD | 91.142% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 96.962% |
| Mesoblast Limited | 118.7 Million USD | 98.529% |
| MultiCell Technologies, Inc. | 202.58 USD | -862002.873% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 94.724% |
| Genscript Biotech Corporation | 417.73 Million USD | 99.582% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -177.18% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -42.177% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | 57.631% |
| Biomind Labs Inc. | 735.54 Thousand USD | -137.437% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | 42.289% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | 86.563% |
| Skye Bioscience, Inc. | 4.61 Million USD | 62.159% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -385.516% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | 40.402% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -1134.082% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -1189.015% |
| Arch Therapeutics, Inc. | 5.87 Million USD | 70.253% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -6690.497% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -16.839% |
| Q BioMed Inc. | 4.1 Million USD | 57.507% |
| GB Sciences, Inc. | 1.75 Million USD | 0.731% |
| Alpha Cognition Inc. | 1.22 Million USD | -43.108% |
| CSL Limited | 12.18 Billion USD | 99.986% |
| Agentix Corp. | 50 Thousand USD | -3392.896% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 97.418% |
| Enzolytics Inc. | 996.33 Thousand USD | -75.287% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | 6.49 Million USD | 73.094% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -583.295% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | 2.25 Million USD | 22.668% |
| argenx SE | 20 Million USD | 91.268% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 96.167% |
| HST Global, Inc. | 98.31 Thousand USD | -1676.308% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -602.174% |
| Halberd Corporation | 150 Thousand USD | -1064.299% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 75.308% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -16980.176% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 35.525% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | 27.162% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -661.673% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -1074.841% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -770.543% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.19 Million USD | 20.612% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 91.409% |
| Kadimastem Ltd | 891.22 Thousand USD | -95.96% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.71 Million USD | 62.932% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -598.071% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | 33.6 Thousand USD | -5096.834% |
| Cell Source, Inc. | 9.25 Million USD | 81.128% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -130.949% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -130.949% |
| Affymax, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -260.625% |
| Itoco Inc. | 228.37 Thousand USD | -664.721% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -727.799% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | 64.952% |
| International Stem Cell Corporation | 4.17 Million USD | 58.199% |
| CytoDyn Inc. | 30.07 Million USD | 94.193% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -396.366% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | 77.667% |
| SYBLEU INC | 477.5 Thousand USD | -265.748% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -1325.672% |
| Rebus Holdings, Inc. | 310 Thousand USD | -463.37% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | 63.118% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -2698.212% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 19.921% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | 78.999% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | 79.657% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -12.277% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -551.66% |
| Neutra Corp. | 54.15 Thousand USD | -3124.847% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | 4.566% |
| PureTech Health plc | 25.51 Million USD | 93.154% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -42.657% |
| IXICO plc | 472.02 Thousand USD | -269.992% |
| IntelGenx Technologies Corp. | 15.5 Million USD | 88.733% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 97.195% |
| CSL Limited | 12.18 Billion USD | 99.986% |
| Cellectis S.A. | 92.77 Million USD | 98.118% |